Evidence map›Paper›PMID 39726191›Full record

ArticleJournal of neuroendocrinology2025

Earlier diagnosis of small intestine neuroendocrine tumours (SI-NETs) through transformation of the South Wales NET service.

Harriet L Gould, Kapish Amin, Thanos Karategos, Sarah Abbas, Susannah Olive, Mathoorika Sivananthan, Ayeesha Rela, Harriet Reed, Catherine Powell, Janu Navaratnam and 16 more

Abstract read
In one paragraph

Article in Journal of neuroendocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Harriet L GouldCardiff University, Cardiff, UK.ORCID 0009-0009-4094-6734
Kapish AminCardiff University, Cardiff, UK.
Thanos KarategosSurgical Directorate, Cardiff and Vale University Health Board, Cardiff, UK.
Sarah AbbasSurgical Directorate, Cardiff and Vale University Health Board, Cardiff, UK.
Susannah OliveSouth Wales Neuroendocrine Tumour Service, Department of Gastroenterology, Cardiff and Vale University Health Board, Cardiff, UK.
Mathoorika SivananthanCardiff University, Cardiff, UK.
Ayeesha RelaCardiff University, Cardiff, UK.
Harriet ReedCardiff University, Cardiff, UK.
Catherine PowellSouth Wales Neuroendocrine Tumour Service, Department of Gastroenterology, Cardiff and Vale University Health Board, Cardiff, UK.
Janu NavaratnamSouth Wales Neuroendocrine Tumour Service, Department of Gastroenterology, Cardiff and Vale University Health Board, Cardiff, UK.ORCID 0000-0002-4569-5761
Rwth Ellis-OwenDepartment of Radiology, Cardiff and Vale University Health Board, Cardiff, UK.
Patrick FieldingDepartment of Radiology, Cardiff and Vale University Health Board, Cardiff, UK.
Dipanjali MondalDepartment of Radiology, Cardiff and Vale University Health Board, Cardiff, UK.
Steve KiharaSouth Wales Neuroendocrine Tumour Service, Swansea Bay University Health Board, Swansea, UK.
Gethin WilliamsDepartment of Surgery, Royal Gwent Hospital, Newport, UK.
Carys MorganVelindre Cancer Centre, Cardiff, UK.
Justyna WitczakDepartment of Endocrinology, Cardiff and Vale University Health Board, Cardiff, UK.
Julie CornishSurgical Directorate, Cardiff and Vale University Health Board, Cardiff, UK.
Sarah GwynneSouth Wales Neuroendocrine Tumour Service, Swansea Bay University Health Board, Swansea, UK.
James HorwoodSurgical Directorate, Cardiff and Vale University Health Board, Cardiff, UK.
Jared TorkingtonSurgical Directorate, Cardiff and Vale University Health Board, Cardiff, UK.
Rachel HargestCardiff University, Cardiff, UK.
Adam ChristianDepartment of Cellular Pathology, Cardiff and Vale University Health Board, Cardiff, UK.
Michael DaviesSurgical Directorate, Cardiff and Vale University Health Board, Cardiff, UK.
James AnsellSurgical Directorate, Cardiff and Vale University Health Board, Cardiff, UK.
Mohid S KhanCardiff University, Cardiff, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small intestine neuroendocrine tumours (SI-NETs) are often diagnosed late with a UK median of 3 years and high misdiagnosis rates. Previous studies, largely based on patient surveys, offer little data on improving diagnosis. In 2017, the South Wales NET service underwent a nationally commissioned, systematic transformation, aiming to improve diagnosis through the development of a gastroenterology and surgical referral network, and education of these specialities. This study aims to assess the impact of the transformation on SI-NET diagnosis times and misdiagnosis rates using accurate hospital data, along with the diagnostic routes and investigations used for SI-NETs. We retrospectively analysed the hospital records of 224 patients diagnosed with SI-NETs referred to the South Wales NET service (110 pre-transformation and 114 post-transformation). Following the service transformation, there was a significant reduction in diagnosis times from a median of 12.5-5.2 months (p < .05), at an earlier stage (cases with metastases reduced from 77% to 62%), and reduced misdiagnosis rates from 40% to 25%. Colonoscopy, used to investigate the presenting gastrointestinal symptoms in 42% of patients prior to diagnosis, identified an abnormality in only 28%, compared with 97% with computed tomography (CT) scans. A gastroenterology and surgical referral network across hospitals may improve diagnosis in SI-NETs, leading to earlier detection and reducing misdiagnosis rates. Further exploration of GP interactions is needed. Caution is needed following negative colonoscopy in patients with persistent lower gastrointestinal symptoms as this could lead to missed SI-NET diagnosis if further abdominal imaging is not undertaken.

Indexed as

Early Detection of CancerIntestinal NeoplasmsIntestine, SmallNeuroendocrine TumorsAdultAgedAged, 80 and overDiagnostic ErrorsFemaleHumansMaleMiddle AgedRetrospective StudiesWalescarcinoidclinical presentationdiagnosisdiagnosis timesgastrointestinal symptomsinvestigationsneuroendocrine cancerneuroendocrine neoplasmneuroendocrine tumour

Identifiers

PMID39726191
PMCPMC11975795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.